Clinical Research Associate interview questions, with worked answers

How to use these questions

Many rounds include a scenario from a site visit: a consent form signed after the first study procedure, a missing safety report, an investigator who never has time. Say what you check, whom you tell and how you follow it up. In the other questions, give a real site and trial you worked on, with the phase and the therapy area.

What a clinical research associate is expected to know

• The rules: ICH-GCPApply the international guideline on Good Clinical Practice at every visit, and spot where a site falls short., the international guideline, and the trial laws of the countries of your sites.
• The work: monitoringPlan and run monitoring visits, on site and remote, and write reports that lead to action. from selection to close-out, and how a trial runsKnow how a trial runs from protocol to report, and what each site and each document is for. from protocol to report.
• The safety side: adverse event reportingMake sure sites report adverse events correctly and on time, and follow serious ones up. and its deadlines.
• The systems: data capture and trial managementWork in the trial's data capture and management systems: entries, queries and reports., and the site's own records.

Systems are named in ads side by side and none is a must everywhere: Medidata Rave, Veeva Vault, Oracle Clinical One and REDCap are common, with Excel lists for site status. The sponsor chooses them; interviewers care more about what you check than which screen you check it in.

Sites from start to finish

How would you run site selection for a new study?

What they check: choosing sites that will recruit and do good work.

Short answer: "I start with a feasibility questionnaire, then visit the promising sites: do they have the patients the protocol needs, an investigator with time, trained staff, the equipment, and space for the drug. My report says which sites can do the study and what risks I see."

The full answer: Ask for the site's numbers from earlier similar trials; optimism about recruitment is the most common weak point of site selection.

A weak answer: "I pick the big hospitals." Follow-up: "A famous site has no study nurse." Say what you report.

What happens at a site initiation visit?

What they check: starting a site right.

Short answer: "A site initiation visit is the training before the first patient: the protocol, eligibility, informed consent, safety reporting, the systems and the study files. I check that every person who will work on the study is trained and listed, and that the drug or device and the documents are in place."

The full answer: Ask the team to walk you through the first patient's visit; gaps show at once.

A weak answer: "I present the slides." Follow-up: "The investigator leaves after ten minutes." Say what you do.

Walk me through a routine monitoring visit, including source data verification.

What they check: the core of the job.

Short answer: "Before the monitoring visit I review the data and open items. On site I check consent, eligibility, safety reports and source data verification, checking the data in the system against the patients' records, plus the drug accounting and the site file. I end with the investigator, then write the report and a follow-up letter."

The full answer: Tie each finding to ICH-GCP or the protocol, and give the site a date to fix it; findings without a date tend to come back.

A weak answer: "I check all the data." Follow-up: "You have one day and forty patients." Say what you check first.

How do you check informed consent?

What they check: the first protection of every patient.

Short answer: "Informed consent is the patient's documented, voluntary agreement to take part after being told what the study means. I check that the current approved version was used, that it was signed and dated by the right people before any study procedure, and that the process is written in the patient's record."

The full answer: When a new version is approved, check that patients still in the study signed it at their next visit.

A weak answer: "If there is a signature it is fine." Follow-up: "A blood test was done an hour before the signature." Say what you do.

How would you run the close-out of a site at the end of a trial?

What they check: finishing as carefully as starting.

Short answer: "At close-out I check that every query is resolved, every safety report is followed up, the study drug or devices are counted and returned or destroyed as agreed, and the site file is complete for archiving. Then I tell the site how long to keep the records and close it in the systems."

The full answer: An inspection can come years later; a complete file at close-out is what the site will rely on.

A weak answer: "We send a thank-you letter." Follow-up: "Two consent forms are missing at close-out." Say what you do.

Safety, deviations and quality

A site has many protocol deviations. What do you do?

What they check: turning findings into better work.

Short answer: "A protocol deviation is any departure from the approved protocol, from a visit outside its window to a patient who did not meet the criteria. I make sure each is recorded, find the pattern behind them, agree a fix with the investigator, retrain the team and tell the trial team if patient safety or key data are affected."

The full answer: Important deviations may have to be reported to the authority or ethics committee; know the rules of your countries.

A weak answer: "I note them in my report." Follow-up: "The same deviation happens again next month." Say what you escalate.

How do you make sure adverse events are reported correctly and on time?

What they check: the safety duties of a site.

Short answer: "An adverse event is any unwanted medical event in a patient during the trial, related or not. A serious adverse event is one that leads to death, is life-threatening, needs a hospital stay or causes lasting harm, and the site must report it to the sponsor quickly, usually within a day. At each visit I look for events in the records that were not reported."

The full answer: Check hospital letters, lab values and concomitant medication; unreported events hide there.

A weak answer: "The investigator decides what to report." Follow-up: "You find a hospital stay from last month that nobody reported." Say what you do today.

You suspect misconduct at a site. What do you do?

What they check: honesty and the right channel.

Short answer: "I write down the facts I saw, such as identical signatures or data that cannot be true, without accusing anyone, and tell my line manager and the sponsor's quality team at once. They decide on an audit. I do not investigate alone or warn the site."

The full answer: Most odd data have a harmless reason, but misconduct puts patients and the whole trial at risk; escalation protects both.

A weak answer: "I would ask the site to fix it quietly." Follow-up: "The investigator is a friend of the sponsor's medical director." Say what changes.

How do you keep the trial master file ready for an inspection?

What they check: the documents that tell the story of a trial.

Short answer: "The trial master file, the TMF, holds the essential documents that show the trial was run properly, and each site keeps its own part, the investigator site file. I file my documents promptly, check the site file at each visit and fix gaps before they grow."

The full answer: An inspector reads the file to rebuild what happened; a document filed months late raises questions even if it is correct.

A weak answer: "Someone in the office does the filing." Follow-up: "The site's delegation log is out of date." Say what it means.

An authority announces an inspection at one of your sites. How do you prepare?

What they check: calm work under the rules of each country.

Short answer: "I tell the trial team and quality, check the site file and the open findings, make sure the investigator and staff know where everything is, and plan who answers what. The rules depend on the country: the EU CTR in the EU, the US FDA's rules in the US, the MHRA in the UK."

The full answer: Do not create or change documents to look better; correct openly what was wrong, with the date of the correction.

A weak answer: "We tidy up the files." Follow-up: "The inspector asks you about a finding you never followed up." Say how you answer.

Recruitment, data and travel

What is risk-based monitoring, and how does it change your work?

What they check: how monitoring works today.

Short answer: "Risk-based monitoring means focusing on the data and processes that matter most for patient safety and the trial's results, instead of checking every value. Central data review points to sites and topics at risk, and visits, on site or remote, go where the risk is."

The full answer: You need to read central reports well and explain to a site why you check some things closely and others not at all.

A weak answer: "We check less, so it is quicker." Follow-up: "Central review flags a site with no adverse events at all." Say what you do.

How do you handle open queries before database lock?

What they check: clean data on time.

Short answer: "A query is a question the data team or the system raises about a value, such as a missing date or a result out of range. I track open queries per site, agree a weekly time with the study nurse to answer them, and help with the source documents where needed."

The full answer: Fix the cause of repeated queries at the site; answering the same query every week costs everyone time.

A weak answer: "Data management chases them." Follow-up: "Lock is in five days and one site has a hundred open queries." Say your plan.

A site is not recruiting. What do you do?

What they check: helping a site rather than blaming it.

Short answer: "I ask why: no patients who fit, no time, a referral path that does not work, patients who refuse. Then we agree on steps, such as screening lists, help with referrals or materials the ethics committee has approved, and I report honestly if the site cannot recruit."

The full answer: Recruitment problems often start at site selection; feed what you learn back into the next one.

A weak answer: "I push the investigator." Follow-up: "The sponsor wants to close the site." Say what you recommend.

How do you plan travel and visits across several sites?

What they check: a job that is often on the road.

Short answer: "I plan visits by what each site needs, the risk, the recruitment and the open items, then group them so travel makes sense, and use remote visits where the protocol and the site allow. Reports and follow-up letters are written within the agreed days, wherever I am."

The full answer: Keep a simple weekly plan with each site's next visit and open items; it is what your line manager will ask for.

A weak answer: "I go where I am called." Follow-up: "Two sites need you on the same day." Say how you decide.

How do you use data and AI tools in monitoring?

What they check: sensible use of new tools with patients' data.

Short answer: "I use the dashboards of the data capture system to find late entries, odd values and open queries before a visit. AI tools may help draft a visit report from my notes or summarise a protocol amendment; I never put patient data into a tool the sponsor has not approved, and I check every draft against what I saw."

The full answer: The report is signed by you and stays your responsibility, whatever drafted it.

A weak answer: "AI can do the monitoring." Follow-up: "A drafted report lists a finding you never made." Say what you do.

Senior rounds

How would you coach a clinical trial assistant who wants to become a CRA?

What they check: developing people in a field that needs more of them.

Short answer: "I take the clinical trial assistant on visits with me, first watching, then doing parts of the visit with me reviewing, and let them write reports that I correct. We go through ICH-GCP cases together, and I give them one easy site to co-monitor before they hold their own."

The full answer: As a senior clinical research associate or lead clinical research associate you are judged partly by the CRAs you bring on.

A weak answer: "They should read the guideline." Follow-up: "Their first report misses a serious finding." Say how you handle it.

Your CV for these questions

Each job on your CV invites the questions above: which trials, which sites, which findings and which inspections. Give those stories a line each, written so a CRA manager wants to hear more:

Put your CV beside a clinical research associate job you want with the free score; the area it finds thin is the one to rehearse first, with a real site told without study codes or patient details.